Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Location: Fort Worth TX, Dallas TX, Georgetown TX, Austin TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05519475
Phase2, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Southlake TX, Dallas TX, Tyler TX, Round Rock TX,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
for
Macular Edema
Location: Southlake TX, Dallas TX, Austin TX, The Woodlands TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06962839
Phase2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Get alerts for new trials in your area by subscribing now
New
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
for
Locally Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA, East Brunswick NJ
Sponsor: Fortvita Biologics (USA)Inc.
Sex: All
Age: 18+
Code: NCT06349408
Phase1, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Irving TX, Houston TX, Memphis TN, Grand Island NE,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
for
Solid Tumor
Location: Irving TX, Tyler TX, Houston TX, New Orleans LA,
Sponsor: ImmunoGenesis
Sex: All
Age: 18+
Code: NCT06014502
Phase1, Recruiting
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
for
Locally Advanced Unresectable or Metastatic Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Sex: All
Age: 18+
Code: NCT05458219
Phase1, Recruiting
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Austin TX, Houston TX, New York NY,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06167317
Phase1, Recruiting
Study of APR-1051 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Irving TX, Houston TX, San Antonio TX, Cleveland OH,
Sponsor: Aprea Therapeutics
Sex: All
Age: 18+
Code: NCT06260514
Phase1, Recruiting
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX, Grand Rapids MI,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06804824
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis